Tag
Pharma / Healthcare
160 articles
Lipocine Shares Plunge 77% After Trial Miss
Lipocine Inc. shares plunged 77% after its phase‑3 postpartum‑depression drug LPCN 1154 missed the primary endpoint.
The trial of 90 patients showed no statistically significant HAM‑D17 score reductio
Amanta Healthcare Analyst/Investor Meeting April 2026
Amanta Healthcare schedules an in-person group analyst/institutional investor meeting on April 7, 2026, at Kheda, Gujarat.
The meeting includes a site visit and is disclosed under SEBI LODR Regulation
Shelter Pharma Reports Positive Customer Feedback
Shelter Pharma Limited filed a Regulation 30 SEBI LODR disclosure regarding positive customer feedback on its product range.
Feedback reflects customer satisfaction in quality, effectiveness, and expe
Firstsource Named Leader in 2026 Healthcare Payer Assessments
Firstsource Solutions named a Leader in Everest Group's Healthcare Payer Intelligent Operations PEAK Matrix® Assessment 2026, among 9 of 33 globally evaluated providers.
Firstsource also recognized as
Sanofi India 70th AGM Notice, 11 Resolutions
Sanofi India Limited's 70th AGM is scheduled for April 29, 2026 at 3:30 PM IST via VC/OAVM with 11 resolutions.
Total FY2025 dividend of ₹123/share proposed (₹75 interim already paid; ₹48 final pendin
Alkem Labs Doubles Ujjain Plant Investment to ₹1036 Cr
Alkem Laboratories' Board approved increasing Ujjain greenfield facility investment from ₹533 crore to ₹1,036 crore.
The facility will be set up on ~30 acres allotted by DMIC Vikram Udyogpuri Limited,
Hemant Surgical Signs C-ARM Deal with GBT Korea
Hemant Surgical Industries Ltd. entered a C-ARM Development and Supply Agreement with GBT Korea Co., Ltd., Republic of Korea.
The agreement aims to develop and localize x-ray generators, electronic co
Lupin Completes Acquisition of VISUfarma
Lupin Limited completed acquisition of VISUfarma B.V., a European ophthalmology specialty pharma company, from GHO Capital Partners LLP.
The deal adds over 60 branded ophthalmic products and commercia
LatentView Invests USD 3M in Healtheon AI
LatentView Analytics' US subsidiary executed SAFE Notes for USD 3 million strategic investment in Healtheon AI INC. on April 01, 2026.
Healtheon AI, a Delaware corporation incorporated March 20, 2026,
Emcure Acquires Cutimed Inc., Merges with Mantra
Emcure's step-down subsidiary Mantra Pharma Inc. acquired 100% of Cutimed Inc. for up to CAD $5.05 million cash on April 01, 2026.
Cutimed Inc., a Québec-incorporated cosmetics and dermatological prod
Lupin Acquires 43.38% Stake in MPPI Philippines
Lupin's wholly owned subsidiary Nanomi B.V. acquires 43.38% minority stake (11,794,497 shares) in Multicare Pharmaceuticals Philippines, Inc. for up to USD 39.6 million.
MPPI reported PHP 2,096.6 mill
Alembic Pharma: Chirayu Amin Appointed Executive Chairman
Mr. Chirayu Amin (DIN: 00242549) appointed as Executive Chairman of Alembic Pharmaceuticals effective 1st April, 2026 for 5 years.
Appointment was approved by shareholders at the 15th AGM held on 5th
Alembic Pharma Pranav Amin MD Re-appointment Effective
Alembic Pharmaceuticals intimates BSE and NSE of Pranav Amin's Managing Director re-appointment effective 1st April 2026.
Shareholders approved the re-appointment at the 15th AGM on 5th August 2025 fo
Glenmark Takes Direct U.S. Control of RYALTRIS®
Glenmark Pharmaceuticals assumes end-to-end commercialization and distribution of RYALTRIS® in the U.S. effective April 1, 2026.
RYALTRIS® is Glenmark's first innovative product in the U.S., a fixed-d
Lupin Completes VISUfarma B.V. Acquisition
Lupin's wholly owned Dutch subsidiary Nanomi B.V. completed acquisition of entire share capital of VISUfarma B.V., Netherlands on April 1, 2026.
VISUfarma and its wholly owned subsidiaries now become
Piramal Pharma Completes Kenalog® Acquisition from BMS
Piramal Pharma's step-down subsidiary Piramal Critical Care B.V. completed acquisition of Kenalog® from Bristol-Myers Squibb.
The acquisition strengthens Piramal's Complex Hospital Generics portfolio
Chandra Bhagat Pharma Opens Dubai Branch Office
Chandra Bhagat Pharma Limited disclosed opening a new international branch office in Dubai, UAE under SEBI Reg. 30.
The branch, formed as a Representative Office in Sharjah Media City Free Zone, comme
Alembic Pharma Appoints Rajkumar Baheti as Director
Alembic Pharmaceuticals appointed Mr. Rajkumar Baheti (DIN: 00332079) as Non-Executive Non-Independent Director effective 1st April, 2026.
Shareholders approved the appointment via Postal Ballot dated
Saharsh Davuluri Appointed CEO & MD Neuland Labs
Neuland Laboratories appoints Saharsh Davuluri as CEO & MD effective April 1, 2026, succeeding Sucheth Davuluri.
Sucheth Davuluri transitions to Executive Vice Chairman; contract services revenues tri
Nikhil Chopra Resigns as CEO, JB Chemicals
JB Chemicals & Pharmaceuticals discloses cessation of Nikhil Chopra as CEO and KMP effective March 31, 2026.
Chopra had earlier resigned as Whole-time Director effective January 21, 2026, citing perso
Shelter Pharma Launches FitKick Pro Commercially
Shelter Pharma Limited discloses commercial launch of new product FitKick Pro, available from 30th March 2026.
FitKick Pro is listed on Amazon and targets the domestic market; international expansion
Max Healthcare ESOP 2022: 57,461 Shares Allotted
Max Healthcare's NRC approved allotment of 57,461 equity shares on April 1, 2026 under ESOP Scheme 2022.
Shares were allotted at ₹350 per share (₹10 face value, ₹340 premium) in dematerialized form wi
Hemant Surgical Signs SKD Agreement with Sonomed Escalon USA
Hemant Surgical Industries Ltd. executed an SKD Manufacturing Agreement with Sonomed Escalon, USA for ophthalmic ultrasound diagnostic devices.
The agreement aims to undertake Semi Knocked Down assemb
Alembic Pharma Senior Manager Nilesh Wadhwa Resigns
Alembic Pharmaceuticals disclosed resignation of Mr. Nilesh Wadhwa, Head – Formulation Business Development, effective 31st March, 2026.
Resignation was originally submitted on 16th December 2025 and
Aurobindo Pharma Board to Consider Buyback
Aurobindo Pharma's Board will meet on April 6, 2026 to consider a proposal for buyback of fully paid-up equity shares.
The disclosure is made under Regulations 29(1) and 29(2) of SEBI Listing Obligati
AstraZeneca Pharma India Senior Management Appointments
AstraZeneca Pharma India appoints Dr. Shashank Srinivasan as Medical Director – Oncology Business Unit, effective April 1, 2026.
Mr. Venkat Natarajan promoted to Director – Market Access Business Unit
Cipla Board Meeting May 13 Q4 Results
Cipla's Board of Directors will meet on May 13, 2026 to approve Q4 and FY2026 audited financial results.
The board will also consider recommending a final dividend for the year ended March 31, 2026.
T
IKS Health Acquihires AI Firm ThinkDTM
IKS Health announces strategic acquihire of ThinkDTM, an AI-native product and digital services company, including its founder Tij Bedi.
Tij Bedi assumes role of EVP and General Manager, Patient Acces
Astonea Labs Acquires 25.74% Stake Damaira Pharma
Astonea Labs Limited acquired ~25.74% equity stake in Damaira Pharmaceuticals Private Limited for INR 6.25 crore cash consideration.
52 lakh equity shares acquired at INR 12.02/share, funded via varia
Pfizer Limited Senior Management Personnel Changes
Pfizer Limited disclosed two senior management exits under SEBI Listing Regulations Regulation 30.
Deepak Rakheja, Strategic Partnerships & International Markets Lead, resigned effective July 8, 2026.
Eris Lifesciences Closes Velbiom Probiotics Acquisition
Eris Lifesciences announces successful closure of the Probiotics Business acquisition from Velbiom Probiotics Private Limited.
The transaction was initially intimated to exchanges on March 20, 2026, a
Ind Swift Labs Allots 1.25 Lakh ESOP Shares
Ind Swift Laboratories allotted 1,25,000 equity shares under Employee Incentive Scheme 2014 on 31st March 2026.
Shares were allotted at exercise price of Rs. 10/- (face value), with no premium, to eli
Apollo Healthco Acquires Apollo Consumer Products Ltd
Apollo Healthco Limited (AHL), a 78.88% subsidiary of Apollo Hospitals, acquired 100% of Apollo Consumer Products Limited (ACPL) for ₹9 lakh.
ACPL, incorporated on March 11, 2026, is a newly formed FM
Zydus Lifesciences Senior Management Transition: Mayank Satpal
Zydus Lifesciences filed a Regulation 30 disclosure on March 31, 2026, reporting a senior management transition.
Mr. Mayank Satpal has transitioned out of Senior Management due to an organizational re
Novelix Pharma Allots 11.5L Shares on Warrant Conversion
Novelix Pharmaceuticals' board on March 30, 2026 approved allotment of 11,50,000 equity shares at Rs. 20 each via promoter warrant conversion.
Allottees are Srinidhi Fine-Chemicals LLP (11,00,000 shar
Novelix Pharmaceuticals Director Jivamohan Valluri Resigns
Novelix Pharmaceuticals Ltd discloses resignation of Non-Executive Director Mr. Jivamohan Divakar Valluri effective 30th March 2026.
Resignation is due to pre-occupation and personal commitments; no m
AGEasy Launches India's First Smart Diaper Pants
Antara Assisted Care Services (AACSL), wholly owned subsidiary of Max India Ltd, launched AGEasy Adult Diaper Pants with proprietary Smart Liquid Distribution™ technology.
The product is India's first
Lupin Gets FDA Tentative Approval for Sugammadex Injection
Lupin received tentative U.S. FDA approval for Sugammadex Injection (200 mg/2 mL and 500 mg/5 mL) ANDA on March 31, 2026.
The product is bioequivalent to Merck's Bridion® Injection, used for reversing
Cohance Lifesciences Appoints Sisir K. Mishra as Company Secretary
Cohance Lifesciences Ltd appointed Mr. Sisir K. Mishra as Company Secretary, Compliance Officer, and KMP effective April 9, 2026.
Mr. Mishra is a Fellow Member of ICSI with an LL.M. and over two decad
Corona Remedies Acquires Wokadine® from Dr. Reddy's
Corona Remedies acquires Wokadine® brand from Dr. Reddy's Laboratories, marking its fifth inorganic acquisition, effective March 30, 2026.
Wokadine® is ranked #2 in India's INR 648 Cr Povidone Iodine
Torrent Pharma Sells UNM Foundation Shares
Torrent Pharmaceuticals sold 50,000 equity shares of UNM Foundation (Section 8 Company) to its holding company Torrent Investments Limited on March 30, 2026.
Total consideration received was ₹5,00,000
Ind-Swift Labs Postal Ballot: Management Restructuring 2026
Ind-Swift Laboratories issued a Postal Ballot Notice with 4 Special Resolutions for senior management restructuring effective February 1, 2026.
N.R. Munjal steps down as MD to become Chairman & Whole-
Kwality Pharma Postal Ballot: Two Independent Directors Appointed
Kwality Pharmaceuticals Limited passed two special resolutions via postal ballot appointing two Independent Directors for 5-year terms each.
Both resolutions received near-unanimous approval with 99.9
Cipla MD CEO Umang Vohra Resigns, SMPs Designated
Cipla's MD & Global CEO Umang Vohra (DIN: 02296740) resigned as Director effective 1st April 2026, upon completion of his tenure.
Achin Gupta takes charge as the new Managing Director and Global CEO o
Alkem Labs Incorporates WOS in Dubai UAE
Alkem Laboratories incorporated a 100% wholly owned subsidiary, Alkem Pharmaceuticals Scientific Office FZ LLC, in Dubai Healthcare City, UAE on 4th February 2026.
The WOS has an authorized and subscr
HCG Approves INR 254 Crore Subsidiary Investments
HCG's board approved investment of up to INR 98 Crore in wholly owned subsidiary HCG NCHRI LLP for debt repayment.
HCG also approved up to INR 155.66 Crore to acquire an additional 34% stake in Vizag
Biocon Subsidiary Renamed to Biocon Biologics Ireland
Biocon Limited intimates BSE and NSE of a name change in its step-down subsidiary effective March 27, 2026.
Biosimilar Collaborations Ireland Limited, a subsidiary of Biocon Biologics Limited, is rena
Aurobindo Pharma Appoints Independent Director via Postal Ballot
Aurobindo Pharma conducted a Postal Ballot via remote e-voting from February 27 to March 28, 2026, for one special resolution.
Members approved appointment of Dr. (Mrs.) Punita Kumar Sinha as Independ
Lupin's Nanomi Stake in MPPI Rises to 56.28%
Lupin's subsidiary Nanomi B.V. (Netherlands) saw its stake in Multicare Pharmaceuticals Philippines rise from 51% to 56.28% effective March 30, 2026.
MPPI bought back 2,813,811 equity shares from exis
MedPlus Board Meeting Scheduled May 29, 2026
MedPlus Health Services Board meeting scheduled on May 29, 2026 to approve audited standalone and consolidated financial results.
Results pertain to Q4 and full financial year ended March 31, 2026; fi
Sun Pharma Philogen Fibromun Nidlegy Clinical Updates
Sun Pharma's partner Philogen reported that Fibromun's Phase II FLASH (STS) and GLIOSTAR (glioblastoma) trials both failed to meet their primary endpoints.
Nidlegy's Phase II Duncan study showed 52.6%
HCG Rights Issue: 82.9L Shares Allotted at ₹512
HealthCare Global Enterprises' Rights Issue Committee approved allotment of 82,94,566 equity shares at ₹512 each on March 27, 2026.
Issue opened March 11 and closed March 25, 2026, with record date of
Pharmaids Pharma Divests Step-Down Subsidiary for ₹3L
Pharmaids Pharmaceuticals sold its step-down subsidiary Siri Labvivo Diet Pvt Ltd effective March 27, 2026.
The subsidiary was divested by material subsidiary Adita Bio Sys Pvt Ltd for a consideration
Sun Pharma Presents 14 Abstracts at AAD 2026
Sun Pharma will present 14 abstracts at the 2026 AAD Annual Meeting (March 27–31, Denver, Colorado) covering dermatology and immunology.
Key data covers ILUMYA (psoriasis), LEQSELVI (alopecia areata),
Aptus Pharma Postal Ballot: Bonus Issue & Capital Hike
Aptus Pharma Limited filed newspaper advertisement of Postal Ballot Notice with BSE under Regulation 30 and 47 of SEBI LODR, 2015.
Board approved two resolutions: increase in Authorised Share Capital
Fortis Malar Hospitals Postal Ballot Three Resolutions Passed
Fortis Malar Hospitals Limited discloses postal ballot results for three resolutions passed on March 27, 2026, via e-voting.
Mr. Bidesh Chandra Paul (DIN: 08596135) appointed as Director and Whole-Tim
Syngene Leadership Overhaul: CEO Change, KMS Executive Role
Syngene's Board approved Kiran Mazumdar Shaw's transition from Non-Executive to Executive Chairperson, effective April 1, 2026, for 5 years.
MD & CEO Peter Bains resigned, effective close of business
SPARC Senior Management Change: Bhowmik Exits, Lakkad Appointed
Sun Pharma Advanced Research Company Limited disclosed a senior management change via circular resolution dated March 27, 2026.
Dr. Shravanti Bhowmik resigned as VP – Operations Management, effective
Alkem Laboratories Appoints Samsher Kumar Deo Senior Management
Alkem Laboratories disclosed appointment of Mr. Samsher Kumar Deo at a senior management position effective 27th March, 2026.
Mr. Samsher Kumar Deo holds a B.Sc. degree and has over 29 years of experi
Eris Lifesciences Issues ₹75 Cr Corporate Guarantee
Eris Lifesciences executed a ₹75 crore corporate guarantee favouring its wholly owned subsidiary Eris Bionxt Private Limited.
The guarantee secures a term loan sanctioned by HDFC Bank to EBPL for repa
Medi Assist Postal Ballot: Sunita Cherian Director Appointment
Medi Assist Healthcare Services Ltd seeks member approval via postal ballot for appointment of Ms. Sunita Rebecca Cherian (DIN: 10188170) as Non-Executive, Non-Independent Director.
Ms. Cherian, forme
P&G Health Board Meet May 26, 2026
Procter & Gamble Health Limited schedules Board of Directors meeting for May 26, 2026.
Board will consider and approve Audited Financial Statements for FY ended March 31, 2026.
Board will also conside
Jupiter Hospitals Wins BKC Land for 400-Bed Hospital
Jupiter Life Line Hospitals received MMRDA's acceptance of its tender for ~10,026.44 sqm land at BKC, Mumbai on 80-year lease.
The one-time lease premium payable to MMRDA is ~Rs. 354 Crores for Plot N
Dr. Lal PathLabs Board Meet April 30 FY26 Results
Dr. Lal PathLabs Board meeting scheduled on April 30, 2026 to approve Q4 and FY26 audited financial results.
Trading window for company securities will remain closed from April 1 to May 2, 2026 (both
Sanofi Consumer Healthcare India First Investor Meet
Sanofi Consumer Healthcare India Limited (SCHIL) held its first Institutional Investor Meet on 24th March 2026, filed under Regulation 30 of SEBI LODR.
Company reported ₹880 crore turnover, ~37% Profi
Shreehas Tambe Appointed Biocon CEO & MD
Biocon Limited appoints Shreehas Tambe as CEO & Managing Director, effective April 1, 2026, following board and NRC approval.
Kedar Upadhye named CFO; outgoing CEO Siddharth Mittal transitions to anot
Novartis India Board Director Appointment & Cessation
Novartis India Board appointed Ms. Gowree Gokhale as Additional Non-Executive Independent Director effective April 01, 2026 for five years.
Ms. Sandra Martyres completes her second and final term as I
Antara Noida Care Home Gets NABH Accreditation
Antara's Noida Sector 66 care home becomes the first senior care facility in Noida district to receive NABH Care Home Accreditation.
This is the second NABH-accredited facility in Antara's network, ma
Cipla Postal Ballot: Achin Gupta Appointed MD & CEO
Cipla Limited completed its Postal Ballot on 25th March 2026, passing all 4 resolutions with requisite majority.
Mr. Achin Gupta (DIN: 09491674) was appointed as Director, Managing Director & Global C
Cipla Global CSO Pradeep Bhadauria Resigns
Cipla's Global Chief Scientific Officer Pradeep Bhadauria has resigned to pursue interests outside Cipla.
Bhadauria was a member of the Management Council and employee of Cipla USA Inc., a wholly owne
HCG Tanzania Subsidiary Wound Up Effective March 2026
HealthCare Global Enterprises Limited disclosed the winding up of its wholly owned indirect subsidiary, Healthcare Global (Tanzania) Private Limited, effective March 02, 2026.
HCG Tanzania was a non-o
Global Health Analyst Meet with PNB Malaysia
Global Health Limited schedules a virtual one-to-one investor meeting with Permodalan Nasional Berhad, Malaysia on March 31, 2026.
The meeting is disclosed under Regulation 30 read with Schedule III o
Dr. Reddy's ESOP Share Allotment 3,675 Shares
Dr. Reddy's Laboratories allotted 3,675 equity shares of Re.1 each on March 26, 2026, under its ADR Stock Options Scheme, 2007.
Shares were issued at two exercise prices: 575 shares at Re.1 each and 3
Sanofi Consumer Healthcare Investor Meet Recording Available
Sanofi Consumer Healthcare India Limited has made the video recording of its Institutional Investor Meet publicly available.
The Institutional Investor Meet was held on Tuesday, 24th March 2026, via v
ET Planners Dissolved via NCLT Order
NCLT New Delhi Bench dissolved ET Planners Private Limited, a step-down wholly-owned subsidiary of Max Healthcare Institute Limited, on March 25, 2026.
The voluntary liquidation was initiated on Septe
Narayana Hrudayalaya Investor Meeting Scheduled March 27
Narayana Hrudayalaya Limited has intimated a scheduled group investor meeting on Friday, 27th March 2026 at 10:30 AM IST.
The meeting is a physical group meet with Premji, Magma & Arohi, arranged by I
JB Chemicals NCLT Corrigendum Order Amalgamation Torrent
J.B. Chemicals & Pharmaceuticals filed intimation under Regulation 30 of SEBI LODR regarding NCLT Ahmedabad Bench's Corrigendum Order dated March 24, 2026.
The Corrigendum Order relates to the propose
Asston Pharma Board Meet on Key Appointments
Asston Pharmaceuticals' Board will meet on 30th March 2026 to consider multiple key management appointments.
Agenda includes appointment of CFO, two Additional Directors, and noting statutory auditor
Gujarat Kidney IPO Fund Utilisation Variation Postal Ballot
Gujarat Kidney and Super Speciality Limited seeks shareholder approval via postal ballot for three resolutions including IPO fund utilisation variation.
Company proposes replacing Vadodara women's hos
Jagsonpal Pharma ₹40 Crore Buyback Postal Ballot
Jagsonpal Pharmaceuticals seeks shareholder approval via postal ballot to buyback up to 16 lakh equity shares at ₹250/share for ₹40 crores.
The buyback represents 2.39% of paid-up equity capital and 1
CuraTeQ Biologics Signs EU Biosimilars Distribution Deal
CuraTeQ Biologics, a wholly owned subsidiary of Aurobindo Pharma, signed a marketing and distribution agreement with STADA Arzneimittel AG.
STADA will market and distribute two EMA-approved biosimilar
Samrat Pharmachem Board Meet May 30 FY26 Results
Samrat Pharmachem Ltd scheduled a Board meeting on May 30, 2026 to approve FY26 audited standalone financial results.
The meeting will be held at 2:00 PM at the Corporate Office in Andheri (West), Mum
Kerala Ayurveda Issues ₹40 Cr NCDs Private Placement
Kerala Ayurveda Ltd's board approved issuance of 4,000 Series 'A' unlisted, secured, redeemable NCDs aggregating ₹40 crores via private placement on March 25, 2026.
NCDs carry 12% p.a. interest on red
Sagility Investor Day: Q3 FY26 Revenue Up 29%
Sagility Limited held its Investor and Analyst Day on March 25, 2026, presenting business strategy, AI capabilities, and financial performance.
Q3 FY26 revenue grew 29.1% YoY to $222.0M; Adjusted EBIT
Parmax Pharma Appoints Bhakti Aghera as Company Secretary
Parmax Pharma Limited appointed Ms. Bhakti Aghera (ICSI Membership No. A68683) as Company Secretary and Compliance Officer (KMP) effective March 25, 2026.
The appointment was approved by the Board on
TAKE Solutions Launches AI Health Platform Take.Health
TAKE Solutions launched Take.Health, an AI-driven digital health companion targeting India's USD 197 billion preventive healthcare market by 2030.
The platform offers AI-powered lab report analysis, p
Emcure Pharma Postal Ballot: Muralidharan Independent Director Appointment
Emcure Pharmaceuticals issued a Postal Ballot Notice dated March 24, 2026, under Regulation 30 of SEBI LODR, to appoint Mr. C S Muralidharan as Independent Director.
Mr. Muralidharan (DIN: 00014740),
Aptus Pharma Bonus Issue 3:2, Capital Hike
Aptus Pharma's Board approved increasing Authorized Share Capital from ₹7.15 crore to ₹25 crore, subject to member approval.
Board recommended a 3:2 bonus equity share issue, offering 3 bonus shares f
JB Chemicals Amalgamation with Torrent Pharma: NCLT Order
JB Chemicals & Pharmaceuticals is being amalgamated with Torrent Pharmaceuticals under a Scheme of Amalgamation.
NCLT Ahmedabad Bench uploaded its Order on March 23, 2026 for the first motion applicat
Sanofi India Analyst/Investor Meet April 2026
Sanofi India Limited has scheduled in-person analyst/institutional investor meetings in Mumbai on 1st April 2026.
Meetings will commence at 9:00 AM IST and discussions will be restricted to publicly a
IKS Health, Certilytics Expand AI Partnership
IKS Health and Certilytics expand strategic partnership to bridge payer-provider gap using Agentic AI and human-in-the-loop oversight.
The collaboration targets three use cases: prior authorization (7
JB Chemicals Postal Ballot: Five Director Appointments Approved
J. B. Chemicals & Pharmaceuticals Ltd declared postal ballot results on March 24, 2026 for five ordinary resolutions on director appointments.
All five resolutions — including Aman Mehta as Managing D
Torrent Pharma-JB Chemicals Amalgamation NCLT Order
Torrent Pharmaceuticals filed Regulation 30 intimation regarding NCLT Ahmedabad Bench's order on JB Chemicals amalgamation first motion application.
NCLT Ahmedabad uploaded the order on its website on
Mangalam Drugs Board Meeting: CS Change
Mangalam Drugs & Organics Ltd schedules a board meeting on March 26, 2026 at its Mumbai registered office.
Ms. Anuradha Pandey resigns as Company Secretary & Compliance Officer (KMP) effective March 2
Niva Bupa Investor Meet ICICI Securities March 2026
Niva Bupa Health Insurance will participate in an investor group meet organized by ICICI Securities on March 30, 2026.
The meeting is a group meet scheduled at Grand Hyatt, Santacruz, Mumbai.
No unpub
Star Health Analyst Investor Meet March 2026
Star Health schedules four back-to-back institutional investor meetings in Mumbai on March 27, 2026.
Meetings filed under SEBI LODR Regulation 30; held at shorter notice due to investor-side business
Natco Pharma Approves Agrochemicals Demerger Scheme
Natco Pharma's board approved demerger of its Agrochemicals Business into wholly owned subsidiary Natco Crop Health Sciences Limited, with Appointed Date October 1, 2026.
Share entitlement ratio is 1:
Abate Eye Hospital Launches Kerala's First Alcon Vision Suite
Abate AS Industries Ltd launches Kerala's first Alcon Vision Suite (AVS) at Abate Eye Hospital, a fully integrated ophthalmic care ecosystem.
The AVS features NGENUITY® 1.5 3D Visualization System and
Emcure Pharma Re-appoints Three Independent Directors
Emcure Pharmaceuticals passed three special resolutions via postal ballot on March 20, 2026 to re-appoint independent directors.
Mr. Vijay Gokhale (5 years), Dr. Vidya Yeravdekar (3 years), and Dr. Sh
Emcure Pharma Postal Ballot Three IDs Re-appointed
Emcure Pharmaceuticals disclosed postal ballot results under Regulation 44(3) of SEBI LODR, with three special resolutions passed effective March 20, 2026.
All three resolutions re-appointing independ
Lupin Allots 1.36 Lakh ESOP Shares
Lupin's Operations and Finance Committee allotted 1,35,892 fully paid-up equity shares under ESOP on March 24, 2026.
Shares of ₹2 face value each were allotted upon exercise of vested options by emplo
Wanbury Launches Pediatric Coriminic CPM, NS Drops
Wanbury Limited launched Coriminic CPM Drops (Chlorpheniramine Maleate) and Coriminic NS Nasal Drops for children under 4 years.
The launches address DCGI restrictions on fixed-dose combinations (Chlo
Solara Pharma Rights Issue Second Final Call
Solara Active Pharma's Rights Issue Committee approved a Second & Final call of ₹112.50 per partly-paid Rights Share on March 24, 2026.
The call comprises ₹3.00 towards face value and ₹109.50 towards
Biogen Pharmachem Approves 1:6 Bonus Issue
Biogen Pharmachem's board approved a 1:6 bonus issue of 15,04,33,833 equity shares funded from securities premium.
Authorized share capital to increase from Rs. 91 crore to Rs. 108 crore, subject to s
Coral Labs Completes Dehradun Ointment Capacity Expansion
Coral Laboratories Limited has completed capacity expansion of its General Pharmaceuticals Formulation (Ointment) unit at Dehradun.
The expanded facility has a new capacity of 360,000 kgs and has comm
Aster DM Healthcare Analyst Meet March 2026
Aster DM Healthcare will host a group investor/analyst meeting in Bengaluru on March 27, 2026.
The meeting is organized by ICICI Securities Limited and will be held in-person.
The company has confirme
Venmax Drugs Allots 28 Lakh Shares via Warrant Conversion
Venmax Drugs allotted 28,00,000 equity shares at Rs. 20 each to two non-promoter warrant holders on March 23, 2026.
Balance exercise price of Rs. 15 per warrant (75% of issue price) was received, aggr
Gujarat Kidney Acquires Parekhs Hospital for ₹77 Cr
Gujarat Kidney and Super Speciality Limited executed acquisition of Parekhs Hospital Private Limited as a wholly owned subsidiary on 22 March 2026.
The acquisition was completed via cash consideration
Wardwizard Healthcare Appoints Yuvraj Priyadarshi Additional Director
Wardwizard Healthcare Limited appointed Mr. Yuvraj Priyadarshi (DIN: 08055832), its current CEO, as Additional Director w.e.f. 23rd March 2026.
The appointment is subject to shareholder approval at th
Apollo Hospitals Acquires 30.58% Stake in AHLL
Apollo Hospitals completed acquisition of 30.58% equity stake in subsidiary Apollo Health and Lifestyle Limited (AHLL) from IFC and IFC EAF.
Total purchase consideration for 41,650,638 equity shares w
Jeena Sikho Lifecare Publishes Ayurvedic Research Studies
Jeena Sikho Lifecare Limited filed a Regulation 30 disclosure regarding publication of academic case studies in IJAR.
Three publications covering Ayurvedic management of chronic liver disease, kidney
Wardwizard Healthcare Board Approves Director Appointment, Management Changes
Wardwizard Healthcare Ltd held its Board meeting on 23rd March 2026, approving multiple governance and management decisions.
CEO Mr. Yuvraj Priyadarshi (DIN: 08055832) appointed as Additional Director
Shalby Krishna Hospital Launches Oncology & Radiotherapy
Krishna Shalby Hospital, Ahmedabad inaugurated its Oncology Department with advanced Radiotherapy facilities under Reg. 30 of SEBI LODR.
The new department offers integrated cancer care with medical,
Metropolis Healthcare 3:1 Bonus Share Allotment
Metropolis Healthcare allotted 15,54,95,826 bonus equity shares on March 23, 2026, in a 3:1 ratio.
Post-allotment paid-up share capital increased to ₹41,46,55,536 comprising 20,73,27,768 equity shares
Amanta Healthcare Promoter Buys 28,800 Shares
Amanta Healthcare discloses Form C under SEBI Insider Trading Regulations for open market purchase by promoter.
Shri Bhavesh Patel, Promoter, CMD, acquired 28,800 equity shares on March 27 and March 3
Hannah Joseph Hospital Promoter Buys 3.84 Lakh Shares
Dr. Mosesjoseph Arunkumar, Promoter & MD, acquired 3,84,000 equity shares of Hannah Joseph Hospital Limited on 27.03.2026.
The acquisition was made on-market via BSE at a total transaction value of ₹2
Sudhir Sethi Acquires 7500 Beryl Drugs Shares
Beryl Drugs Limited discloses promoter Sudhir Sethi's acquisition of 7,500 equity shares (0.14%) via open market on 23 March 2026.
Post-acquisition, Sudhir Sethi's holding in Beryl Drugs rises from 9.
NephroPlus Files Writ Against GST Demand ₹2.51 Cr
Nephrocare Health Services Ltd filed writ petition WP(C)/646/2026 before J&K High Court on April 02, 2026 challenging GST orders.
GST authorities raised a total demand of ₹2.51 Cr (tax ₹1.46 Cr, inter
Glenmark Pharma GST Demand Order ₹32 Crore
Glenmark Pharmaceuticals received a GST adjudication order for FY 2019-20 and 2020-21 from Mumbai East Commissionerate.
Order demands ₹16.05 crore GST (CGST/SGST), equivalent penalty of ₹16.05 crore,
Marksans Pharma Gets USFDA Approval Benzonatate Capsules
Marksans Pharma received final USFDA approval for its ANDA for Benzonatate Capsules USP, 100 mg & 200 mg (Rx).
The product is bioequivalent to Pfizer's Tessalon Capsules and treats persistent cough, b
Fortis Hospitals ₹149 Crore Income Tax Demand
Fortis Hospitals Limited, a wholly owned subsidiary of Fortis Healthcare, received an income tax demand of ₹149.12 crore for AY 2021-22.
The assessment order dated March 27, 2026 was issued by the Inc
Alembic Pharma Postal Ballot: Baheti Appointment Approved
Alembic Pharmaceuticals filed Postal Ballot voting results under Regulation 44(3) of SEBI LODR Regulations, 2015 dated March 31, 2026.
Both resolutions — appointment and professional fee payment for M
Panacea Biotec Receives ₹22.88 Crore GST Demand
Panacea Biotec received a Demand Order dated March 30, 2026 from CGST Sub-Commissionerate Mohali raising ₹22.88 Crore in GST dues and penalty.
The demand comprises ~₹11.44 Crore alleged unpaid GST and
GlaxoSmithKline Pharma ₹2.01 Cr TDS Demand Order
GlaxoSmithKline Pharmaceuticals received a Final Order from TDS Authority INT Tax Circle 2(3)(2) with ₹2.01 Crore demand liability.
The demand covers TDS default u/s 201 for AY 2020-21, comprising ₹1.
AstraZeneca Pharma India RPT Postal Ballot Results
AstraZeneca Pharma India passed two ordinary resolutions approving material related party transactions with AstraZeneca UK Limited and AstraZeneca AB, Sweden.
Both resolutions received ~83% votes in f
Lyka Labs Appoints New Cost Auditor FY26-27
Lyka Labs' Board met on 31st March 2026 and approved appointment of M/s. Nidhi Subhash Tibrewala & Co. as Cost Auditors.
The new firm fills a casual vacancy for FY2025-26 caused by resignation of M/s.
Granules Life Sciences Gets US FDA VAI Classification
Granules Life Sciences Private Limited (GLS), a wholly owned subsidiary of Granules India, received VAI classification from US FDA for its Shamirpet, Telangana facility.
The Establishment Inspection R
Novartis India Delhi HC Admits DVAT Petition
Delhi High Court admitted Novartis India's writ petition on March 27, 2026, challenging a DVAT assessment for AY 2013–14.
The disputed demand totals approximately ₹10.89 crore in tax and interest plus
Jubilant Pharmova IEPF Dividend & Share Transfer Notice
Jubilant Pharmova filed a Regulation 47 SEBI disclosure on March 30, 2026 regarding IEPF transfer of unclaimed dividends and shares.
Unclaimed dividends from FY2018-19 onwards are due for transfer to
Prism Medico Clarifies Stock Price Movement
Prism Medico & Pharmacy Ltd responded to BSE/MSEI query on significant recent price movement in its securities.
Company states all material disclosures under Regulation 30 of SEBI LODR have been made
Haleos Labs Updates Email, Website After Rename
Haleos Labs Limited (formerly SMS Lifesciences India Limited) intimates BSE and NSE of updated email IDs and website following company name change.
Name change was approved via Postal Ballot (results
Haleos Labs Postal Ballot: ₹20 Cr Guarantee Approval
Haleos Labs seeks shareholder approval via postal ballot for a ₹20 Crore corporate guarantee to RBL Bank for subsidiary Mahi Drugs' ECB facility.
The transaction qualifies as a Material RPT under SEBI
Wockhardt Zaynich® Gets CDSCO SEC Favourable Recommendation
CDSCO's Subject Expert Committee granted a favourable recommendation for marketing permission of Wockhardt's novel antibiotic Zaynich® (Zidebactam/Cefepime) for Gram-negative infections.
Zaynich® demo
MedPlus Subsidiary Drug License Suspended 3 Days
Optival Health Solutions, a MedPlus subsidiary, received a 3-day drug license suspension for its Parkal Main Road, Telangana store.
The suspension order was issued by the Assistant Director, Drugs Con
Syngene Tax Litigation Update: ₹43 Cr Refund Granted
Syngene International received an order dated February 6, 2026 granting a tax refund of ₹43,15,79,510 (including interest) for AY 2016-17.
The refund follows a partial appeal victory at NFAC for AY 20
Themis Medicare Postal Ballot: 4 Resolutions Passed
Themis Medicare Limited passed 4 resolutions via remote e-voting postal ballot concluded on 27th March 2026.
Shareholders approved material RPTs with VMIPL/Themis Distributors, GTBL, and inter-se shar
MedPlus Subsidiary Drug License Suspended, Karnataka
Optival Health Solutions Pvt Ltd, MedPlus subsidiary, received a 3-day drug license suspension for its Dharwad, Karnataka store.
The suspension was ordered by Assistant Director, Drugs Control Adminis
Sanofi India Tax Assessment Order FY2022-23
Sanofi India received a final income tax assessment order for FY 2022-23 (AY 2023-24) on 27th March 2026.
The Assessment Unit determined a tax liability of INR 12,36,99,710 (including interest) on tra
Fortis Hospitals ₹117 Cr Income Tax Demand AY2024-25
Fortis Hospitals Limited, a wholly-owned subsidiary of Fortis Healthcare, received an income tax demand of ₹117.04 crore for AY 2024-25.
The assessment order was issued by Income Tax Authority on Marc
Fortis Malar ₹20.82L Tax Demand Deleted, ₹41.11L Refund
Fortis Malar Hospitals' rectification application u/s 154 of Income Tax Act successfully processed by CPC, Bengaluru for AY 2024-25.
Income tax demand of INR 20.82 lakhs raised under Section 143(1) In
Bandhan MF Crosses 5% Stake in Amanta Healthcare
Bandhan Small Cap Fund acquired 21,603 equity shares (0.0556%) of Amanta Healthcare on March 25, 2026 via open market.
Post-acquisition, Bandhan Mutual Fund's holding in Amanta Healthcare rose to 5.01
Aarti Pharmalabs US-FDA Inspection Form 483 Issued
US-FDA inspected Aarti Pharmalabs' Unit-IV at Tarapur, Maharashtra, concluding on 27th March 2026.
Inspection concluded with issuance of Form 483 carrying one procedural observation.
Company will subm
Narayana Hrudayalaya Clarifies SMVD Hospital Transfer
Narayana Hrudayalaya clarifies media reports on SMVD Narayana Hospital relate to a previously disclosed arrangement under Regulation 30.
Subsidiary NVDSHPL executed a Business Transfer Agreement with
Panacea Biotec Tax Appeal Dismissed, ₹9.38 Cr Demand
CIT(A) dismissed Panacea Biotec's three appeals against ACIT penalty orders dated December 24, 2025 vide orders dated March 25, 2026.
The dismissed appeals relate to penalty for alleged under-reportin
Alembic Pharma Gets USFDA Approval Paroxetine ER Tablets
Alembic Pharmaceuticals received USFDA final approval for Paroxetine Extended-Release Tablets USP, 12.5 mg on 27th March 2026.
The approved sANDA is therapeutically equivalent to Paxil CR Tablets 12.5
Astonea Labs EGM: IPO Proceeds Reallocation Approved
Astonea Labs Limited held its EGM on 27th March 2026 at Panchkula, Haryana, with 8 resolutions on the agenda.
Key resolution approved reallocation of unutilised IPO proceeds for equity acquisition in
Themis Medicare Income Tax Notice ₹13.32 Crore
Themis Medicare received a Section 226(3) Income Tax Act notice on 25th March 2026 for outstanding tax demands.
Aggregate tax demand is approx. ₹13.32 crore across AY 2017-18 (₹8.71 cr), AY 2018-19 (₹
Fredun Pharma Director Acquires 1.06L Shares via Warrants
Fredun Pharmaceuticals discloses insider trading form under SEBI PIT Regulations 2015 for director shareholding change.
Fredun Nariman Medhora acquired 1,06,668 equity shares via preferential allotmen
Torrent Pharma NCLT Corrigendum Order on JB Chem Merger
Torrent Pharmaceuticals intimates BSE/NSE of a Corrigendum Order dated 24th March 2026 by NCLT Ahmedabad in the JB Chemicals merger.
The Corrigendum Order relates to the proposed amalgamation of JB Ch
JB Chemicals NCLT Corrigendum Order on Torrent Merger
JB Chemicals discloses NCLT Ahmedabad Corrigendum Order dated March 24, 2026 on its amalgamation with Torrent Pharmaceuticals.
The filing is a follow-up to an earlier intimation dated March 24, 2026 u
Zydus Lifesciences GST Demand Order ₹3.28 Cr
Zydus Lifesciences received a GST demand order of ₹3.28 Cr (including interest and penalty) for FY2019-20.
The order was passed by Assistant Commissioner of State Tax, Gujarat under Section 74 of CGST
NATCO Pharma Postal Ballot: 4 Directors Re-appointed
NATCO Pharma discloses postal ballot voting results under Regulation 44 of SEBI LODR, 2015 for four special resolutions.
All four resolutions to re-appoint key executive directors effective April 1, 2
Fortis Malar Hospitals Income Tax Rectification Order ₹48L
Fortis Malar Hospitals received an income tax rectification order dated March 19, 2026 for AY 2018-19.
The order raises an additional demand of ₹48,22,435 on account of interest under Section 234D.
Th
Lupin Gets Tentative FDA Approval for Pitolisant Tablets
Lupin received tentative U.S. FDA approval for its ANDA for Pitolisant Tablets in 4.45mg and 17.8mg strengths.
The product is bioequivalent to Wakix® and will be manufactured at Lupin's Nagpur facilit
Wardwizard Healthcare ₹231.60 Cr RPT Postal Ballot FY27
• Wardwizard Healthcare (BSE: 512063) issued a Postal Ballot Notice dated 23rd March 2026 seeking approval for 15 material RPTs totalling ~₹231.60 crore for FY 2026-27.
• The company carries a deeply
Tyche Industries Receives ANVISA Brazil GMP Certificate
Tyche Industries received a GMP Compliance Certificate from ANVISA, Brazil for its Kakinada, Andhra Pradesh manufacturing facility.
The certificate is valid for two years from March 16, 2026 to March
GSK Pharma Receives Rs 23.21 Cr Tax Demand
GlaxoSmithKline Pharmaceuticals received a tax demand of Rs 23.21 crore from CPC for Assessment Year 2023-24.
The demand arose post scrutiny assessment; the company is filing an appeal before the appe
Sanofi Consumer Healthcare India Postal Ballot Notice
Sanofi Consumer Healthcare India dispatched a Postal Ballot Notice on 23rd March 2026 for four ordinary resolutions via remote e-voting.
Member approvals sought for material RPTs with Opella India (₹1
MedPlus Subsidiary Drug License Suspended in Karnataka
Optival Health Solutions, a MedPlus subsidiary, received a 3-day drug license suspension for its Mandya, Karnataka store.
The suspension was issued by the Assistant Director, Drugs Control Administrat
Shalby Postal Ballot Re-appoints Independent Director Joshi
Shalby Limited passed a Special Resolution via postal ballot (remote e-voting) to re-appoint Mr. Shyamal Shivkumar Joshi as Independent Director for a second five-year term (May 17, 2026–May 16, 2031)